Matthew Roberts Naunheim, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Otolaryngology | 23 | 2024 | 685 | 6.320 |
Why?
|
Laryngeal Diseases | 10 | 2024 | 244 | 4.480 |
Why?
|
Dysphonia | 6 | 2023 | 144 | 3.290 |
Why?
|
Vocal Cord Paralysis | 8 | 2022 | 272 | 3.090 |
Why?
|
Larynx | 10 | 2024 | 492 | 2.960 |
Why?
|
Patient Preference | 8 | 2024 | 922 | 2.830 |
Why?
|
Voice Disorders | 5 | 2024 | 286 | 2.520 |
Why?
|
Laryngoscopy | 11 | 2024 | 706 | 2.060 |
Why?
|
Voice | 5 | 2024 | 267 | 1.960 |
Why?
|
Laryngeal Neoplasms | 8 | 2024 | 514 | 1.860 |
Why?
|
Laryngostenosis | 4 | 2023 | 167 | 1.450 |
Why?
|
Vocal Cords | 6 | 2022 | 523 | 1.440 |
Why?
|
Neck Injuries | 2 | 2021 | 160 | 1.230 |
Why?
|
Laryngectomy | 4 | 2020 | 243 | 1.210 |
Why?
|
Larynx, Artificial | 3 | 2017 | 69 | 1.120 |
Why?
|
Otorhinolaryngologic Surgical Procedures | 4 | 2021 | 323 | 0.970 |
Why?
|
Voice Quality | 4 | 2020 | 226 | 0.920 |
Why?
|
Choice Behavior | 3 | 2024 | 821 | 0.920 |
Why?
|
Laryngoplasty | 2 | 2021 | 50 | 0.890 |
Why?
|
Glottis | 2 | 2024 | 214 | 0.880 |
Why?
|
Plasmacytoma | 1 | 2024 | 171 | 0.860 |
Why?
|
Laryngeal Edema | 1 | 2023 | 21 | 0.860 |
Why?
|
Microsurgery | 5 | 2024 | 796 | 0.800 |
Why?
|
Artificial Intelligence | 5 | 2024 | 2557 | 0.790 |
Why?
|
Diverticulum | 1 | 2023 | 137 | 0.780 |
Why?
|
Medicare | 10 | 2023 | 6786 | 0.720 |
Why?
|
Tracheostomy | 4 | 2021 | 425 | 0.710 |
Why?
|
Professional Corporations | 1 | 2020 | 9 | 0.710 |
Why?
|
Carcinoma | 3 | 2019 | 2331 | 0.700 |
Why?
|
Fee Schedules | 1 | 2020 | 85 | 0.700 |
Why?
|
Trachea | 3 | 2017 | 1082 | 0.690 |
Why?
|
Esophagus | 3 | 2017 | 1023 | 0.680 |
Why?
|
Fractures, Closed | 1 | 2019 | 88 | 0.610 |
Why?
|
Sickness Impact Profile | 1 | 2019 | 298 | 0.610 |
Why?
|
Fractures, Open | 1 | 2019 | 105 | 0.600 |
Why?
|
Deglutition | 1 | 2019 | 208 | 0.580 |
Why?
|
Reimbursement Mechanisms | 2 | 2020 | 664 | 0.580 |
Why?
|
Video Recording | 3 | 2021 | 955 | 0.580 |
Why?
|
Ownership | 1 | 2020 | 339 | 0.570 |
Why?
|
Occupational Diseases | 2 | 2023 | 1486 | 0.570 |
Why?
|
Amyloidosis | 1 | 2024 | 817 | 0.570 |
Why?
|
Head and Neck Neoplasms | 3 | 2020 | 2882 | 0.560 |
Why?
|
Prosthesis Implantation | 3 | 2017 | 594 | 0.560 |
Why?
|
Bronchoscopy | 1 | 2023 | 911 | 0.550 |
Why?
|
Thyroid Nodule | 1 | 2024 | 760 | 0.550 |
Why?
|
Private Sector | 1 | 2020 | 397 | 0.550 |
Why?
|
Anesthesia, Local | 1 | 2019 | 276 | 0.550 |
Why?
|
Postoperative Care | 2 | 2020 | 1479 | 0.540 |
Why?
|
Lidocaine | 1 | 2019 | 538 | 0.520 |
Why?
|
Tonsillar Neoplasms | 1 | 2016 | 50 | 0.510 |
Why?
|
Steroids | 1 | 2020 | 928 | 0.500 |
Why?
|
Humans | 101 | 2024 | 760621 | 0.500 |
Why?
|
Medicine | 1 | 2023 | 943 | 0.490 |
Why?
|
Pneumonia, Aspiration | 1 | 2015 | 146 | 0.480 |
Why?
|
Office Visits | 1 | 2019 | 597 | 0.480 |
Why?
|
Postoperative Complications | 6 | 2021 | 15697 | 0.480 |
Why?
|
Parotid Neoplasms | 2 | 2017 | 157 | 0.480 |
Why?
|
Emergency Service, Hospital | 4 | 2019 | 7818 | 0.470 |
Why?
|
Ambulatory Surgical Procedures | 1 | 2019 | 465 | 0.460 |
Why?
|
Health Status Indicators | 1 | 2019 | 968 | 0.450 |
Why?
|
Hospital Costs | 2 | 2016 | 976 | 0.440 |
Why?
|
Nasopharyngeal Neoplasms | 1 | 2016 | 286 | 0.430 |
Why?
|
Intubation, Intratracheal | 1 | 2021 | 1328 | 0.420 |
Why?
|
Salivary Ducts | 1 | 2012 | 25 | 0.400 |
Why?
|
Anesthetics, Local | 1 | 2019 | 1001 | 0.400 |
Why?
|
Neurofibromatoses | 1 | 2016 | 299 | 0.390 |
Why?
|
Adenoma, Pleomorphic | 1 | 2012 | 75 | 0.390 |
Why?
|
Retrospective Studies | 30 | 2024 | 80372 | 0.390 |
Why?
|
Prosthesis Design | 2 | 2015 | 2135 | 0.390 |
Why?
|
Quality of Life | 6 | 2023 | 13308 | 0.380 |
Why?
|
Radiation Injuries | 1 | 2019 | 1183 | 0.380 |
Why?
|
Intracranial Arterial Diseases | 1 | 2011 | 22 | 0.380 |
Why?
|
Telemedicine | 3 | 2023 | 3018 | 0.370 |
Why?
|
United States | 23 | 2024 | 72461 | 0.360 |
Why?
|
Ophthalmology | 1 | 2017 | 549 | 0.360 |
Why?
|
Leukemia, Biphenotypic, Acute | 1 | 2010 | 32 | 0.350 |
Why?
|
Prosthesis-Related Infections | 1 | 2015 | 487 | 0.350 |
Why?
|
Functional Laterality | 1 | 2017 | 2253 | 0.350 |
Why?
|
Blast Crisis | 1 | 2010 | 101 | 0.340 |
Why?
|
Gout | 1 | 2017 | 620 | 0.340 |
Why?
|
Middle Aged | 31 | 2024 | 220352 | 0.340 |
Why?
|
Epstein-Barr Virus Infections | 1 | 2016 | 608 | 0.330 |
Why?
|
Voice Training | 2 | 2020 | 44 | 0.330 |
Why?
|
Patient Satisfaction | 1 | 2022 | 3448 | 0.330 |
Why?
|
Disease Management | 1 | 2020 | 2514 | 0.320 |
Why?
|
Health Services Needs and Demand | 1 | 2017 | 1399 | 0.320 |
Why?
|
Psychomotor Performance | 1 | 2017 | 1878 | 0.320 |
Why?
|
Cross-Sectional Studies | 16 | 2024 | 25942 | 0.310 |
Why?
|
Salivary Gland Neoplasms | 1 | 2012 | 304 | 0.310 |
Why?
|
Neoplasms, Multiple Primary | 1 | 2012 | 586 | 0.310 |
Why?
|
Evidence-Based Medicine | 1 | 2020 | 3696 | 0.310 |
Why?
|
Male | 42 | 2024 | 359744 | 0.310 |
Why?
|
Adult | 28 | 2024 | 219994 | 0.300 |
Why?
|
Cost-Benefit Analysis | 4 | 2019 | 5508 | 0.300 |
Why?
|
Connective Tissue Diseases | 1 | 2011 | 286 | 0.300 |
Why?
|
Injections | 2 | 2021 | 830 | 0.300 |
Why?
|
Carcinoma, Squamous Cell | 2 | 2020 | 4024 | 0.290 |
Why?
|
Patient-Centered Care | 1 | 2017 | 1416 | 0.280 |
Why?
|
Female | 41 | 2024 | 391270 | 0.280 |
Why?
|
Aged | 25 | 2024 | 169152 | 0.280 |
Why?
|
Medicaid | 2 | 2019 | 2815 | 0.270 |
Why?
|
Phenotype | 1 | 2024 | 16546 | 0.260 |
Why?
|
Punctures | 3 | 2017 | 370 | 0.260 |
Why?
|
Deglutition Disorders | 3 | 2019 | 626 | 0.240 |
Why?
|
Clinical Competence | 2 | 2017 | 4783 | 0.240 |
Why?
|
Physicians | 1 | 2022 | 4591 | 0.240 |
Why?
|
Cardiac Surgical Procedures | 1 | 2020 | 3620 | 0.240 |
Why?
|
Intracranial Hemorrhages | 1 | 2010 | 844 | 0.230 |
Why?
|
Spine | 1 | 2011 | 1111 | 0.230 |
Why?
|
Reimbursement, Incentive | 2 | 2020 | 542 | 0.230 |
Why?
|
Disability Evaluation | 3 | 2022 | 1826 | 0.220 |
Why?
|
Decision Making | 1 | 2017 | 3925 | 0.220 |
Why?
|
Patient Acceptance of Health Care | 1 | 2017 | 3164 | 0.210 |
Why?
|
Bronchial Neoplasms | 1 | 2023 | 110 | 0.210 |
Why?
|
Esophageal pH Monitoring | 1 | 2024 | 201 | 0.210 |
Why?
|
Severity of Illness Index | 6 | 2022 | 15840 | 0.210 |
Why?
|
Papilloma | 1 | 2023 | 141 | 0.210 |
Why?
|
Nebulizers and Vaporizers | 1 | 2023 | 137 | 0.200 |
Why?
|
Biomedical Research | 1 | 2017 | 3426 | 0.200 |
Why?
|
Aged, 80 and over | 11 | 2021 | 58995 | 0.200 |
Why?
|
Adenoma | 1 | 2012 | 2148 | 0.190 |
Why?
|
Tracheotomy | 2 | 2021 | 167 | 0.190 |
Why?
|
Intracranial Aneurysm | 1 | 2011 | 1276 | 0.190 |
Why?
|
Smiling | 1 | 2021 | 72 | 0.180 |
Why?
|
Fees, Medical | 1 | 2021 | 112 | 0.180 |
Why?
|
Pharyngitis | 1 | 2022 | 220 | 0.170 |
Why?
|
Periodicals as Topic | 1 | 2011 | 1469 | 0.170 |
Why?
|
Trigeminal Nerve | 1 | 2021 | 248 | 0.170 |
Why?
|
Nerve Transfer | 1 | 2021 | 125 | 0.170 |
Why?
|
Administration, Inhalation | 1 | 2023 | 1156 | 0.170 |
Why?
|
Arytenoid Cartilage | 1 | 2019 | 23 | 0.170 |
Why?
|
Injections, Intralesional | 1 | 2020 | 278 | 0.170 |
Why?
|
Otorhinolaryngologic Diseases | 1 | 2020 | 95 | 0.170 |
Why?
|
Epiglottis | 1 | 2019 | 81 | 0.170 |
Why?
|
Laryngitis | 1 | 2019 | 27 | 0.160 |
Why?
|
Marketing of Health Services | 1 | 2020 | 150 | 0.160 |
Why?
|
Capital Financing | 1 | 2019 | 59 | 0.160 |
Why?
|
Magnetic Resonance Imaging, Interventional | 1 | 2021 | 187 | 0.160 |
Why?
|
Vasculitis | 1 | 2023 | 523 | 0.160 |
Why?
|
Speech Production Measurement | 1 | 2019 | 96 | 0.160 |
Why?
|
Edema | 1 | 2023 | 769 | 0.160 |
Why?
|
Managed Competition | 1 | 2018 | 32 | 0.150 |
Why?
|
Cicatrix | 2 | 2021 | 782 | 0.150 |
Why?
|
Respiratory Aspiration | 1 | 2019 | 89 | 0.150 |
Why?
|
Cryptococcosis | 1 | 2019 | 104 | 0.150 |
Why?
|
Practice Management, Medical | 1 | 2020 | 191 | 0.150 |
Why?
|
Software | 3 | 2021 | 4419 | 0.150 |
Why?
|
Gender Identity | 1 | 2023 | 698 | 0.150 |
Why?
|
Music | 1 | 2020 | 245 | 0.150 |
Why?
|
Aerosols | 1 | 2020 | 632 | 0.150 |
Why?
|
Diagnostic Self Evaluation | 1 | 2019 | 225 | 0.150 |
Why?
|
Cost Control | 1 | 2020 | 630 | 0.150 |
Why?
|
Investments | 1 | 2019 | 148 | 0.140 |
Why?
|
Acoustics | 1 | 2019 | 242 | 0.140 |
Why?
|
Facial Paralysis | 1 | 2021 | 345 | 0.140 |
Why?
|
Ranula | 1 | 2017 | 10 | 0.140 |
Why?
|
MP3-Player | 1 | 2016 | 3 | 0.140 |
Why?
|
Polyps | 1 | 2019 | 197 | 0.140 |
Why?
|
Patient Advocacy | 1 | 2019 | 358 | 0.140 |
Why?
|
Palatal Neoplasms | 1 | 2017 | 37 | 0.140 |
Why?
|
State Government | 1 | 2020 | 380 | 0.140 |
Why?
|
Adenoidectomy | 1 | 2018 | 164 | 0.140 |
Why?
|
Noise, Occupational | 1 | 2016 | 26 | 0.140 |
Why?
|
Access to Information | 1 | 2020 | 320 | 0.140 |
Why?
|
Narcotics | 1 | 2019 | 336 | 0.140 |
Why?
|
Physician Incentive Plans | 1 | 2018 | 165 | 0.140 |
Why?
|
Hair Removal | 1 | 2017 | 40 | 0.140 |
Why?
|
Prevalence | 2 | 2024 | 15687 | 0.140 |
Why?
|
Patient Education as Topic | 2 | 2024 | 2315 | 0.140 |
Why?
|
Equipment and Supplies | 1 | 2019 | 275 | 0.140 |
Why?
|
Facial Nerve Injuries | 1 | 2017 | 64 | 0.130 |
Why?
|
Carcinoma, Mucoepidermoid | 1 | 2017 | 89 | 0.130 |
Why?
|
Paranasal Sinuses | 1 | 2019 | 265 | 0.130 |
Why?
|
Rheumatic Diseases | 1 | 2023 | 639 | 0.130 |
Why?
|
Granulation Tissue | 1 | 2015 | 92 | 0.130 |
Why?
|
Parotid Gland | 1 | 2017 | 175 | 0.130 |
Why?
|
Young Adult | 7 | 2024 | 58741 | 0.130 |
Why?
|
Prosthesis Fitting | 1 | 2015 | 75 | 0.130 |
Why?
|
Device Approval | 1 | 2017 | 165 | 0.130 |
Why?
|
Health Care Sector | 1 | 2017 | 196 | 0.130 |
Why?
|
Tonsillectomy | 1 | 2018 | 268 | 0.120 |
Why?
|
Case-Control Studies | 3 | 2023 | 22053 | 0.120 |
Why?
|
Research Design | 1 | 2011 | 6180 | 0.120 |
Why?
|
Bicycling | 1 | 2016 | 176 | 0.120 |
Why?
|
Job Satisfaction | 1 | 2019 | 539 | 0.120 |
Why?
|
Internationality | 1 | 2020 | 1004 | 0.120 |
Why?
|
Hearing Loss, Noise-Induced | 1 | 2016 | 144 | 0.120 |
Why?
|
Laser Therapy | 2 | 2024 | 1089 | 0.120 |
Why?
|
Disease Transmission, Infectious | 1 | 2020 | 558 | 0.120 |
Why?
|
Decision Trees | 1 | 2016 | 506 | 0.120 |
Why?
|
Conflict of Interest | 1 | 2019 | 549 | 0.120 |
Why?
|
Treatment Outcome | 8 | 2021 | 65017 | 0.120 |
Why?
|
Monitoring, Intraoperative | 1 | 2021 | 942 | 0.120 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2011 | 10344 | 0.120 |
Why?
|
Endoscopy | 1 | 2024 | 1838 | 0.110 |
Why?
|
Pharynx | 3 | 2023 | 432 | 0.110 |
Why?
|
Precancerous Conditions | 1 | 2021 | 977 | 0.110 |
Why?
|
Health Surveys | 1 | 2024 | 4063 | 0.110 |
Why?
|
Adrenal Cortex Hormones | 1 | 2023 | 1869 | 0.110 |
Why?
|
Ambulatory Care Facilities | 1 | 2020 | 926 | 0.110 |
Why?
|
Infection Control | 1 | 2020 | 983 | 0.110 |
Why?
|
Hair | 1 | 2017 | 497 | 0.110 |
Why?
|
Benchmarking | 1 | 2019 | 1044 | 0.110 |
Why?
|
Product Surveillance, Postmarketing | 1 | 2017 | 452 | 0.110 |
Why?
|
Drug Industry | 1 | 2019 | 789 | 0.110 |
Why?
|
Perioperative Care | 1 | 2020 | 1037 | 0.100 |
Why?
|
Costs and Cost Analysis | 2 | 2015 | 1677 | 0.100 |
Why?
|
Coronavirus Infections | 2 | 2020 | 3085 | 0.100 |
Why?
|
Pneumonia, Viral | 2 | 2020 | 3205 | 0.100 |
Why?
|
Adolescent | 5 | 2024 | 87810 | 0.100 |
Why?
|
Language | 1 | 2022 | 1533 | 0.100 |
Why?
|
Free Tissue Flaps | 1 | 2017 | 327 | 0.100 |
Why?
|
Facial Transplantation | 1 | 2015 | 221 | 0.100 |
Why?
|
Drug-Eluting Stents | 1 | 2019 | 757 | 0.100 |
Why?
|
Radiotherapy | 1 | 2019 | 1504 | 0.100 |
Why?
|
Breast | 1 | 2021 | 1963 | 0.100 |
Why?
|
Circle of Willis | 1 | 2011 | 79 | 0.090 |
Why?
|
Autoimmune Diseases | 1 | 2023 | 2250 | 0.090 |
Why?
|
Models, Animal | 1 | 2017 | 2117 | 0.090 |
Why?
|
Pandemics | 5 | 2023 | 8624 | 0.090 |
Why?
|
Prosthesis Failure | 1 | 2015 | 1206 | 0.090 |
Why?
|
Hospitals | 1 | 2023 | 3928 | 0.090 |
Why?
|
Quality-Adjusted Life Years | 1 | 2016 | 1724 | 0.080 |
Why?
|
Risk Factors | 3 | 2023 | 74359 | 0.080 |
Why?
|
Health Care Surveys | 1 | 2017 | 2435 | 0.080 |
Why?
|
Subarachnoid Hemorrhage, Traumatic | 1 | 2009 | 13 | 0.080 |
Why?
|
Iliac Artery | 1 | 2011 | 344 | 0.080 |
Why?
|
Heart Block | 1 | 2011 | 392 | 0.080 |
Why?
|
Blood Cell Count | 1 | 2010 | 397 | 0.080 |
Why?
|
Losartan | 1 | 2011 | 265 | 0.080 |
Why?
|
Anti-Inflammatory Agents | 1 | 2019 | 1796 | 0.080 |
Why?
|
Respiration, Artificial | 1 | 2020 | 2622 | 0.080 |
Why?
|
Insurance Coverage | 1 | 2020 | 1939 | 0.080 |
Why?
|
United States Food and Drug Administration | 1 | 2017 | 1677 | 0.080 |
Why?
|
Logistic Models | 3 | 2021 | 13314 | 0.080 |
Why?
|
Patients | 1 | 2015 | 906 | 0.080 |
Why?
|
Face | 1 | 2015 | 1017 | 0.080 |
Why?
|
Rhinitis | 1 | 2016 | 746 | 0.080 |
Why?
|
Pain, Postoperative | 1 | 2019 | 1721 | 0.080 |
Why?
|
Acute Coronary Syndrome | 1 | 2022 | 2365 | 0.080 |
Why?
|
Patient Selection | 1 | 2020 | 4283 | 0.080 |
Why?
|
Acute Disease | 2 | 2016 | 7269 | 0.080 |
Why?
|
Syncope | 1 | 2011 | 428 | 0.080 |
Why?
|
Insurance, Health | 1 | 2020 | 2501 | 0.070 |
Why?
|
Risk Assessment | 4 | 2024 | 24123 | 0.070 |
Why?
|
Preoperative Care | 1 | 2017 | 2256 | 0.070 |
Why?
|
Pilot Projects | 2 | 2017 | 8555 | 0.070 |
Why?
|
Sinusitis | 1 | 2016 | 990 | 0.070 |
Why?
|
Swine | 1 | 2017 | 5899 | 0.070 |
Why?
|
Vasospasm, Intracranial | 1 | 2009 | 215 | 0.070 |
Why?
|
Pressure | 2 | 2021 | 1156 | 0.070 |
Why?
|
In Situ Hybridization | 1 | 2010 | 1900 | 0.070 |
Why?
|
Leukocyte Count | 1 | 2010 | 1600 | 0.070 |
Why?
|
Occupational Exposure | 1 | 2016 | 1809 | 0.070 |
Why?
|
Diagnosis, Differential | 2 | 2012 | 12965 | 0.070 |
Why?
|
Reproducibility of Results | 1 | 2024 | 20080 | 0.060 |
Why?
|
Tomography, X-Ray Computed | 3 | 2016 | 20509 | 0.060 |
Why?
|
Health Expenditures | 1 | 2018 | 2362 | 0.060 |
Why?
|
Angiography | 1 | 2011 | 1605 | 0.060 |
Why?
|
Pacemaker, Artificial | 1 | 2011 | 815 | 0.060 |
Why?
|
Syndrome | 1 | 2011 | 3280 | 0.060 |
Why?
|
Benzamides | 1 | 2010 | 1369 | 0.060 |
Why?
|
Neoplasm Staging | 1 | 2019 | 11152 | 0.060 |
Why?
|
Aorta | 1 | 2011 | 2039 | 0.050 |
Why?
|
Prospective Studies | 4 | 2021 | 54303 | 0.050 |
Why?
|
Massachusetts | 1 | 2015 | 8803 | 0.050 |
Why?
|
Delivery of Health Care | 1 | 2020 | 5325 | 0.050 |
Why?
|
Hoarseness | 1 | 2022 | 62 | 0.050 |
Why?
|
Socioeconomic Factors | 1 | 2015 | 7806 | 0.050 |
Why?
|
Papilloma, Intraductal | 1 | 2021 | 21 | 0.050 |
Why?
|
Antihypertensive Agents | 1 | 2011 | 2061 | 0.050 |
Why?
|
Mucocele | 1 | 2021 | 51 | 0.050 |
Why?
|
Facial Muscles | 1 | 2021 | 159 | 0.050 |
Why?
|
Child | 3 | 2019 | 79806 | 0.040 |
Why?
|
Time Factors | 2 | 2019 | 40165 | 0.040 |
Why?
|
Relative Value Scales | 1 | 2020 | 86 | 0.040 |
Why?
|
Constriction, Pathologic | 1 | 2023 | 1098 | 0.040 |
Why?
|
Flow Cytometry | 1 | 2010 | 5870 | 0.040 |
Why?
|
Piperazines | 1 | 2010 | 2525 | 0.040 |
Why?
|
Aphonia | 1 | 2019 | 4 | 0.040 |
Why?
|
Coronary Vessels | 1 | 2011 | 3112 | 0.040 |
Why?
|
Contrast Media | 1 | 2012 | 5305 | 0.040 |
Why?
|
Recurrent Laryngeal Nerve | 1 | 2020 | 143 | 0.040 |
Why?
|
Prospective Payment System | 1 | 2020 | 136 | 0.040 |
Why?
|
Cohort Studies | 2 | 2019 | 41335 | 0.040 |
Why?
|
Arkansas | 1 | 2018 | 59 | 0.040 |
Why?
|
Child, Preschool | 2 | 2019 | 42063 | 0.040 |
Why?
|
Aspirin | 1 | 2011 | 3364 | 0.040 |
Why?
|
Research Report | 1 | 2022 | 370 | 0.040 |
Why?
|
Parathyroidectomy | 1 | 2020 | 241 | 0.040 |
Why?
|
Pyrimidines | 1 | 2010 | 3016 | 0.040 |
Why?
|
Platelet Aggregation Inhibitors | 1 | 2011 | 3201 | 0.040 |
Why?
|
Silicone Elastomers | 1 | 2017 | 78 | 0.040 |
Why?
|
Outpatient Clinics, Hospital | 1 | 2020 | 389 | 0.040 |
Why?
|
Tissue Adhesions | 1 | 2019 | 222 | 0.040 |
Why?
|
Computers | 1 | 2020 | 595 | 0.040 |
Why?
|
Electrocardiography | 1 | 2011 | 6414 | 0.040 |
Why?
|
Parotid Diseases | 1 | 2017 | 49 | 0.030 |
Why?
|
Nasal Obstruction | 1 | 2019 | 159 | 0.030 |
Why?
|
Equipment Safety | 1 | 2017 | 253 | 0.030 |
Why?
|
Operating Rooms | 1 | 2023 | 789 | 0.030 |
Why?
|
Absorbable Implants | 1 | 2019 | 345 | 0.030 |
Why?
|
Nerve Regeneration | 1 | 2021 | 791 | 0.030 |
Why?
|
Esophagoscopy | 1 | 2017 | 390 | 0.030 |
Why?
|
Retreatment | 1 | 2017 | 600 | 0.030 |
Why?
|
Cough | 1 | 2019 | 595 | 0.030 |
Why?
|
Thyroidectomy | 1 | 2020 | 902 | 0.030 |
Why?
|
Clinical Protocols | 1 | 2020 | 1440 | 0.030 |
Why?
|
Morphine | 1 | 2019 | 655 | 0.030 |
Why?
|
Dyspnea | 1 | 2022 | 1352 | 0.030 |
Why?
|
Thyroid Gland | 1 | 2020 | 1168 | 0.030 |
Why?
|
Stress, Mechanical | 1 | 2019 | 1666 | 0.030 |
Why?
|
Predictive Value of Tests | 2 | 2021 | 15289 | 0.030 |
Why?
|
Carcinoma, Intraductal, Noninfiltrating | 1 | 2021 | 936 | 0.030 |
Why?
|
Breast Neoplasms | 1 | 2021 | 21025 | 0.030 |
Why?
|
Intraoperative Care | 1 | 2017 | 768 | 0.030 |
Why?
|
Equipment Design | 1 | 2021 | 3520 | 0.030 |
Why?
|
Radiotherapy, Intensity-Modulated | 1 | 2018 | 801 | 0.030 |
Why?
|
Radiotherapy Dosage | 1 | 2018 | 2897 | 0.020 |
Why?
|
Magnetic Resonance Imaging | 2 | 2017 | 36290 | 0.020 |
Why?
|
Biopsy, Needle | 1 | 2017 | 1630 | 0.020 |
Why?
|
Qualitative Research | 1 | 2021 | 2963 | 0.020 |
Why?
|
Hypertension | 1 | 2011 | 8594 | 0.020 |
Why?
|
Educational Measurement | 1 | 2017 | 1248 | 0.020 |
Why?
|
Needs Assessment | 1 | 2016 | 1139 | 0.020 |
Why?
|
Cri-du-Chat Syndrome | 1 | 2009 | 13 | 0.020 |
Why?
|
Odds Ratio | 1 | 2021 | 9716 | 0.020 |
Why?
|
Analysis of Variance | 1 | 2016 | 6238 | 0.020 |
Why?
|
Anxiety | 1 | 2022 | 4538 | 0.020 |
Why?
|
Combined Modality Therapy | 1 | 2019 | 8552 | 0.020 |
Why?
|
Stroke | 1 | 2009 | 9962 | 0.020 |
Why?
|
Disease Progression | 1 | 2023 | 13502 | 0.020 |
Why?
|
Feasibility Studies | 1 | 2016 | 5201 | 0.020 |
Why?
|
Comorbidity | 1 | 2020 | 10551 | 0.020 |
Why?
|
Health Care Costs | 1 | 2019 | 3258 | 0.020 |
Why?
|
Follow-Up Studies | 2 | 2017 | 39261 | 0.020 |
Why?
|
Education, Medical, Graduate | 1 | 2017 | 2363 | 0.020 |
Why?
|
Animals | 1 | 2017 | 167963 | 0.020 |
Why?
|
Immunohistochemistry | 1 | 2017 | 11071 | 0.010 |
Why?
|
Multivariate Analysis | 1 | 2016 | 12159 | 0.010 |
Why?
|
Algorithms | 1 | 2023 | 13981 | 0.010 |
Why?
|
Depression | 1 | 2022 | 8044 | 0.010 |
Why?
|
Databases, Factual | 1 | 2017 | 8035 | 0.010 |
Why?
|
Chronic Disease | 1 | 2016 | 9287 | 0.010 |
Why?
|
Infant | 2 | 2016 | 36060 | 0.010 |
Why?
|
Internship and Residency | 1 | 2017 | 5870 | 0.010 |
Why?
|
Antineoplastic Agents | 1 | 2018 | 13630 | 0.010 |
Why?
|